Although many of these patients end up with a diagnosis of a degenerative ... so the utility of MRI in this common clinical scenario is increasingly questionable, with the exception of those cases in ...

today announced that the U.S. Food and Drug Administration (“FDA”) has granted Fast Track designation to the BRTX-100 program for the treatment chronic lumbar disc disease (“cLDD”).

A more detailed follow up study should be considered to investigate which particular training activities have the most impact on the lumbar spine, and how to modify training methods so as to avoid the ...

announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its BRTX-100 program for treating chronic lumbar disc disease (cLDD). This designation highlights ...